MASS LAYOFFS

Quote






Anonymous said:
I am a rep. I do not have a crystal ball and I do not have anyone on the inside handing me information.

I tok this job because I read the data in MARINE, ANCHOR and JELIS. I read the SPA in regards to the ANCHOR indication.

I believe this drug has a pretty bright future, even if generic lovaza is going to be earlier than previously expected. My concern is the management team.

It appears, from reading the posts on this thread, that someone made a statement that ANCHOR will not be approved. NO ONE THAT WASTES TIME ON THIS SIGHT KNOWS ANYTHING ABOUT WHAT THE FDA WILL DO, nobody, period.

Some positions are being backfilled, in fact, some regions are adding people. You are right though, some positions are NOT being backfilled. Why put a rep in a territory that did not perform and the rep either quit because $63,000 doesn't cut it and if not selling anything, they were not making a bonus OR the rep was fired because they weren't selling. Let's face it, this drug has a good clinical story, lovaza has been the only game in town for a long time and there are docs willing to write it simply becaue there hasn't been a choice until now. If you are not selling any Vascepa, you deserve to be fired. If it is your territory that sucks, then why would anyone back fill that territory? Spend our money somewhere else.
Click to expand...


lol......
NO ONE THAT WASTES TIME ON THIS SIGHT KNOWS ANYTHING ABOUT WHAT THE FDA WILL DO, nobody, period......



it is SITE Skippy. Dumb Azz
 












Anonymous said:
Most the reps want to be the Amarin to be bought or get laid off so they can look for a better job.
Click to expand...

I am one of those reps. I never thought this would be a long term gig. To me it was all about successfully launching a brand, making it more valuable, and waiting for it to be sold. That way I have had some fun and make some money with my stock options and may get lucky enough to get a severance. Not a bad deal.
 






Not me I actually believe in the product, I just hope that the company has the patience to allow us to grow.

Generic Lovaza is a great thing! Where are all those Glaxo trolls now? Hmmmm
 






Anonymous said:
First, most us did not read the data prior to being hired. That's bull crap. We took the job because we needed at job. You seem to "know" a lot about fired reps, territories that don't perform, not working, backfilling etc. especially since you say NO ONE KNOWS ANYTHING. You talk out of your ass, both sides of your ass! Bla bla bla, bla bla bla...
Click to expand...

Ummm, I read up on the drug and did homework on the drug before I took the job. So, speak for yourself
 














































































Stock dropped like a rock today down over 19%. Looks like ANCHOR is hitting a problem where the mineral oil placebo is concerned. FDA remarked it may have had an influence over the lipids.
 






Seriously! As mentioned before from a very insightful poster,no one on this board has any idea what the adcom will do. Let's get this straight. The adcom can advise for or advise against and the FDA makes the final decision. The following is cut directly from the FDA website.

Advisory committees provide independent advice and recommendations to the FDA on scientific and technical matters related to the development and evaluation of products regulated by the Agency. CDER requests advice from advisory committees on a variety of matters, including various aspects of clinical investigations and applications for marketing approval of drug products. Committee members are scientific experts such as physician-researchers and statisticians, as well as representatives of the public, including patients. Although the committees provide recommendations to the Agency, final decisions are made by FDA.

Now, this is the important part. The FDA is a governemental organization. They exist, primarily, to help keep us safe. And like any bureaucracy, they continually try to prove they are relevant. The advisory meetings serve a fantastic purpose. They give experts the opportunity to give input, but as noted above, the FDA has the final decision. Since the bureaucracy is in place, they can't just meet and say," Hey this fish oil rocks, let's approve it. Slam dunk!" They have to do something, and what they do is ask questions. The questions are pretty simple to answer, it is much like us in the field when we have doc that is really engaged and challenging us. It gives us an opportunity to really explain things. We have, or actually Harold Bays, has the oppotunity to explain things. I cant think of a better person than Harold Bays to explain the ANCHOR trial.

This is a great drug, is very different from Lovaza, Niaspan or the fibrates. Plavix had a 19% RRR when added to aspirin in the CURE trial. When the JELIS data is explained, and the commonalities between Vascepa and Elipat are explained, this committee will see the light. 99% of what we are reading today is the ANALYST who make are making money on the panic driven moves we make.

Everyone needs to relax and see waht happens Wednesday. We may have some additional questions to answer, good. It means they are interested.
 






Top Bottom
Back
Quote